Knowledge and practice on magnitude, diagnosis, treatment and prevention strategies of Hepatocellular Carcinoma in Ethiopia: A Systematic Review

被引:0
|
作者
Mekonnen, Daniel [1 ,2 ]
Derbie, Awoke [1 ]
Biadglegne, Fantahun [1 ]
Adem, Yesuf [1 ]
Zenebe, Yohannes [1 ]
Mekonnen, Hailu [3 ]
Gebeyaw, Alemneh [4 ]
Shumet, Abebe [5 ]
Bereded, Fetlework [1 ]
Hailu, Derese [6 ]
Feleke, Berhanu Elfu [7 ]
Mihret, Adane [8 ,9 ]
Saek, Ulrich [10 ]
机构
[1] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Microbiol Immunol & Parasitol, POB 1383, Bahir Dar, Ethiopia
[2] Bahir Dar Univ, Biotechnol Res Inst, Bahir Dar, Ethiopia
[3] Raya Kobo Woreda Hlth Off, Kobo, Ethiopia
[4] Dessie Referral Hosp, Dessie, Ethiopia
[5] Felege Hiwote Referal Hosp, Dept Internal Med, Bahir Dar, Ethiopia
[6] Amhra Publ Hlth Inst, Bahir Dar, Ethiopia
[7] Bahir Dar Univ, Sch Publ Hlth, Dept Epidemiol, Bahir Dar, Ethiopia
[8] Addis Ababa Univ, Coll Med & Hlth Sci, Dept Med Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia
[9] Armauer Hansen Res Inst, Addis Ababa, Ethiopia
[10] Univ Leipzig, Fac Med, Inst Clin Immunol, Leipzig, Germany
关键词
Hepatocellular Carcinoma; Ethiopia; HEPATITIS-B-VIRUS; CHRONIC LIVER-DISEASE; C VIRUS; ALPHA-FETOPROTEIN; NATURAL-HISTORY; NEEDLE-BIOPSY; RISK-FACTORS; FOLLOW-UP; CANCER; INFECTION;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: In Ethiopia, hepatocellular carcinoma (HCC) is the most common cancer with 100% fatality rate. HCC cases in low income countries die within few months following diagnosis. There is lack of information on the burden, risk factors, diagnosis modalities, surveillance strategies and treatment approaches to HCC in Ethiopia. Objective: To analyze the existing evidence related to burden, risk factors, diagnosis modalities, surveillance strategies, and treatment and prevention strategies of HCC in Ethiopia. Methods: All studies done on HCC in Ethiopian irrespective of year of publication and study types were included. Literatures were retrieved from electronic database of PubMedand Cochrane library during September/ 2016 to January 2/2017. Key words and mesh terms such as 'hepatocellular carcinoma', 'hcc', 'hepatoma', 'malignant hepatoma', 'hepatocarcinoma' were used to search for documents. Besides, we searched for articles, guidelines and reviews from world health organizations, lancet and Google scholar sites. Each of the retrieved studies was assessed by two authors for inclusion based on the eligibility criteria, and for quality using the critical appraisal checklist. Qualitative data were synthesized for analyzing the theories of studies. Medley reference manager was used to manage citations. Results: A total of 1448 literatures were retrieved. Eight studies fulfill the eligibility criteria, however, only three were full-fledged articles. HCC is clinically characterized by exhaustion, loss of appetite, rapid loss of weight, epigastric pain, right upper abdominal quadrant pain with a rapidly growing mass, jaundice, and ascites with or without hepatomegaly and splenomegaly. Data on HCC proportion among liver disease patients lies between 16.1%-19.2%. Cirrhosis followed by hepatotoxic indigenous drugs and viral hepatitis were found to be as major risk factor for HCC. In Ethiopia, there is no surveillance activity and no standard staging systems. Furthermore, there was no policy frame - work for management of HCC. Conclusion: As compared to other countries, Ethiopia is far behind in addressing HCC. There is no national policy framework and guideline for the management of HCC. Moreover, HCC is a neglected cancer that is considered as a death penalty by the community. Health professionals working in health facilities and health offices should share the data they have to the scientific community and policy makers, for further searching solutions and informed decision, respectively. An intensified public health strategy on health education and early case detection is of critical importance. In addition concerted effort should be made to develop HCC prevention and treatment modality.
引用
收藏
页码:44 / 56
页数:13
相关论文
共 50 条
  • [21] Clinical Practice Guidelines For the Management of Hepatocellular Carcinoma: A Systematic Review
    Seth, Ishith
    Siu, Adrian
    Hewitt, Lyndel
    Budak, Ulvi
    Farah, Beshoy
    Jaber, Mouhannad
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (01) : 318 - 331
  • [22] Clinical Practice Guidelines For the Management of Hepatocellular Carcinoma: A Systematic Review
    Ishith Seth
    Adrian Siu
    Lyndel Hewitt
    Ulvi Budak
    Beshoy Farah
    Mouhannad Jaber
    Journal of Gastrointestinal Cancer, 2024, 55 : 318 - 331
  • [23] Current diagnosis and systemic treatment of hepatocellular carcinoma Surveillance, diagnosis and strategies for sequence of treatment
    Shmanko, Kateryna
    Galle, Peter R.
    ONKOLOGE, 2022, 28 (04): : 269 - 277
  • [24] Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis
    Tian, Guo
    Yang, Shigui
    Yuan, Jinqiu
    Threapleton, Diane
    Zhao, Qiyu
    Chen, Fen
    Cao, Hongcui
    Jiang, Tian'an
    Li, Lanjuan
    BMJ OPEN, 2018, 8 (10):
  • [25] Causes of and Prevention Strategies for Hepatocellular Carcinoma
    Cabibbo, Giuseppe
    Maida, Marcello
    Genco, Chiara
    Antonucci, Michela
    Comma, Calogero
    SEMINARS IN ONCOLOGY, 2012, 39 (04) : 374 - 383
  • [26] Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review)
    Yang, Shuyue
    Wang, Jiaxin
    Wang, Shidong
    Zhou, Anni
    Zhao, Guiping
    Li, Peng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 61 (02)
  • [27] Milestones in the treatment of hepatocellular carcinoma: A systematic review.
    Gryziak, Maciej
    Wozniak, Krzysztof
    Kraj, Leszek
    Stec, Rafal
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [28] Current diagnosis and systemic treatment of hepatocellular carcinoma. Surveillance, diagnosis and strategies for sequence of treatment
    Shmanko, Kateryna
    Galle, Peter R.
    ONKOLOGIE, 2022, 28 (04): : 269 - 277
  • [29] AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma (May, 10.1097/HEP.0000000000000466, 2023)
    Singal, A. G.
    Llovet, J. M.
    Yarchoan, M.
    Mehta, N.
    Heimbach, J. K.
    Dawson, L. A.
    HEPATOLOGY, 2023, 78 (06) : E105 - E105
  • [30] Evolving strategies in the diagnosis of hepatocellular carcinoma
    Lencioni, Riccardo
    JOURNAL OF HEPATOLOGY, 2011, 54 (01) : 184 - 186